Long noncoding RNA involvement in cancer

  • Maruyama, Reo (Department of Molecular Biology, Sapporo Medical University) ;
  • Suzuki, Hiromu (Department of Molecular Biology, Sapporo Medical University)
  • Received : 2012.10.10
  • Published : 2012.11.30


Recent advances in genome and transcriptome analysis have enabled identification of numerous members of a new class of noncoding RNA, long noncoding RNA (lncRNA). lncRNAs are broadly defined as RNA molecules greater than 200 nt in length and lacking an open reading frame. Recent studies provide evidence that lncRNAs play central roles in a wide range of cellular processes through interaction with key component proteins in the gene regulatory system, and that alteration of their cell- or tissue-specific expression and/or their primary or secondary structures is thought to promote cell proliferation, invasion and metastasis. The biological and molecular characteristics of the large majority of lncRNAs remains unknown, and it is anticipated that improved understanding of the roles played by lncRNAs in cancer will lead to the development of novel biomarkers and effective therapeutic strategies.


Biomarker;Cancer;Gene regulation;Histone modification;LincRNA;Long noncoding RNA;Oncogene;Tumor suppressor


  1. Esteller, M. (2011) Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861-874.
  2. Cabili, M. N., Trapnell, C., Goff, L., Koziol, M., Tazon-Vega, B., Regev, A. and Rinn, J. L. (2011) Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 25, 1915-1927.
  3. Mercer, T. R., Dinger, M. E., Sunkin, S. M., Mehler, M. F. and Mattick, J. S. (2008) Specific expression of long noncoding RNAs in the mouse brain. Proc. Natl. Acad. Sci. U.S.A. 105, 716-721.
  4. Hung, T., Wang, Y., Lin, M. F., Koegel, A. K., Kotake, Y., Grant, G. D., Horlings, H. M., Shah, N., Umbricht, C., Wang, P., Kong, B., Langerod, A., Borresen-Dale, A. L., Kim, S. K., van de Vijver, M., Sukumar, S., Whitfield, M. L., Kellis, M., Xiong, Y., Wong, D. J. and Chang, H. Y. (2011) Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat. Genet. 43, 621-629.
  5. Gutschner, T. and Diederichs, S. (2012) The Hallmarks of Cancer: A long non-coding RNA point of view. RNA Biol. 9, 703-719. doi: 10.4161/rna.20481.
  6. Wang, K. C. and Chang, H. Y. (2011) Molecular mechanisms of long noncoding RNAs. Mol. Cell 43, 904-914.
  7. Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J. and Lee, J. T. (2008) Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322, 750-756.
  8. Nagano, T., Mitchell, J. A., Sanz, L. A., Pauler, F. M., Ferguson-Smith, A. C., Feil, R. and Fraser, P. (2008) The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322, 1717-1720.
  9. Wang, K. C., Yang, Y. W., Liu, B., Sanyal, A., Corces- Zimmerman, R., Chen, Y., Lajoie, B. R., Protacio, A., Flynn, R. A., Gupta, R. A., Wysocka, J., Lei, M., Dekker, J., Helms, J. A. and Chang, H. Y. (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472, 120-124.
  10. Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., Khalil, A. M., Zuk, O., Amit, I., Rabani, M., Attardi, L. D., Regev, A., Lander, E. S., Jacks, T. and Rinn, J. L. (2010) A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409-419.
  11. Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M. C., Hung, T., Argani, P., Rinn, J. L., Wang, Y., Brzoska, P., Kong, B., Li, R., West, R. B., van de Vijver, M. J., Sukumar, S. and Chang, H. Y. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076.
  12. Niland, C. N., Merry, C. R. and Khalil, A. M. (2012) Emerging roles for long non-coding rnas in cancer and neurological disorders. Front Genet. 3, 25.
  13. Chu, C., Qu, K., Zhong, F. L., Artandi, S. E. and Chang, H. Y. (2011) Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol. Cell 44, 667-678.
  14. Yap, K. L., Li, S., Munoz-Cabello, A. M., Raguz, S., Zeng, L., Mujtaba, S., Gil, J., Walsh, M. J. and Zhou, M. M. (2010) Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell 38, 662-674.
  15. Kotake, Y., Nakagawa, T., Kitagawa, K., Suzuki, S., Liu, N., Kitagawa, M. and Xiong, Y. (2011) Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 30, 1956-1962.
  16. Pandey, R. R., Mondal, T., Mohammad, F., Enroth, S., Redrup, L., Komorowski, J., Nagano, T., Mancini-Dinardo, D. and Kanduri, C. (2008) Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell 32, 232-246.
  17. A. W., Fox, A. H., Chess, A. and Lawrence, J. B. (2009) An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol. Cell 33, 717-726.
  18. Tsai, M. C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E. and Chang, H. Y. (2010) Long noncoding RNA as modular scaffold of histone modification complexes. Science 329, 689-693.
  19. Khalil, A. M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea Morales, D., Thomas, K., Presser, A., Bernstein, B. E., van Oudenaarden, A., Regev, A., Lander, E. S. and Rinn, J. L. (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. U.S.A. 106, 11667-11672.
  20. Guttman, M., Donaghey, J., Carey, B. W., Garber, M., Grenier, J. K., Munson, G., Young, G., Lucas, A. B., Ach, R., Bruhn, L., Yang, X., Amit, I., Meissner, A., Regev, A., Rinn, J. L., Root, D. E. and Lander, E. S. (2011) lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477, 295-300.
  21. Kino, T., Hurt, D. E., Ichijo, T., Nader, N. and Chrousos, G. P. (2010) Noncoding RNA gas5 is a growth arrest- and starvation- associated repressor of the glucocorticoid receptor. Sci. Signal. 3, ra8.
  22. Redon, S., Reichenbach, P. and Lingner, J. (2010) The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res. 38, 5797-5806.
  23. Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W. J. and Pandolfi, P. P. (2010) A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033-1038.
  24. Song, M. S., Carracedo, A., Salmena, L., Song, S. J., Egia, A., Malumbres, M. and Pandolfi, P. P. (2011) Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 144, 187-199.
  25. Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E. and Chang, H. Y. (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323.
  26. Yang, Z., Zhou, L., Wu, L. M., Lai, M. C., Xie, H. Y., Zhang, F. and Zheng, S. S. (2011) Overexpression of long non-coding rna hotair predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann. Surg. Oncol. 18, 1243-1250.
  27. Kogo, R., Shimamura, T., Mimori, K., Kawahara, K., Imoto, S., Sudo, T., Tanaka, F., Shibata, K., Suzuki, A., Komune, S., Miyano, S. and Mori, M. (2011) Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 71, 6320-6326.
  28. Kim, K., Jutooru, I., Chadalapaka, G., Johnson, G., Frank, J., Burghardt, R., Kim, S. and Safe, S. (2012) HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene [Epub ahead of print].
  29. Niinuma, T., Suzuki, H., Nojima, M., Nosho, K., Yamamoto, H., Takamaru, H., Yamamoto, E., Maruyama, R., Nobuoka, T., Miyazaki, Y., Nishida, T., Bamba, T., Kanda, T., Ajioka, Y., Taguchi, T., Okahara, S., Takahashi, H., Nishida, Y., Hosokawa, M., Hasegawa, T., Tokino, T., Hirata, K., Imai, K., Toyota, M. and Shinomura, Y. (2012) Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res. 72, 1126-1136.
  30. Pasmant, E., Laurendeau, I., Heron, D., Vidaud, M., Vidaud, D. and Bieche, I. (2007) Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 67, 3963-3969.
  31. Yu, W., Gius, D., Onyango, P., Muldoon-Jacobs, K., Karp, J., Feinberg, A. P. and Cui, H. (2008) Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451, 202-206.
  32. Popov, N. and Gil, J. (2010) Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Epigenetics 5, 685-690.
  33. Iacobucci, I., Sazzini, M., Garagnani, P., Ferrari, A., Boattini, A., Lonetti, A., Papayannidis, C., Mantovani, V., Marasco, E., Ottaviani, E., Soverini, S., Girelli, D., Luiselli, D., Vignetti, M., Baccarani, M. and Martinelli, G. (2011) A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia. Leuk. Res. 35, 1052-1059.
  34. Pasmant, E., Sabbagh, A., Masliah-Planchon, J., Ortonne, N., Laurendeau, I., Melin, L., Ferkal, S., Hernandez, L., Leroy, K., Valeyrie-Allanore, L., Parfait, B., Vidaud, D., Bieche, I., Lantieri, L., Wolkenstein, P. and Vidaud, M. (2011) Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. J. Natl. Cancer Inst. 103, 1713-1722.
  35. Pasmant, E., Sabbagh, A., Vidaud, M. and Bieche, I. (2011) ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 25, 444-448.
  36. Ji, P., Diederichs, S., Wang, W., Boing, S., Metzger, R., Schneider, P. M., Tidow, N., Brandt, B., Buerger, H., Bulk, E., Thomas, M., Berdel, W. E., Serve, H. and Muller-Tidow, C. (2003) MALAT-1, a novel noncoding RNA and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031-8041.
  37. Yamada, K., Kano, J., Tsunoda, H., Yoshikawa, H., Okubo, C., Ishiyama, T. and Noguchi, M. (2006) Phenotypic characterization of endometrial stromal sarcoma of the uterus. Cancer Sci. 97, 106-112.
  38. Lin, R., Maeda, S., Liu, C., Karin, M. and Edgington, T. S. (2007) A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 26, 851-858.
  39. Muller-Tidow, C., Diederichs, S., Thomas, M. and Serve, H. (2004) Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer. Lung Cancer 45(Suppl 2), S145-150.
  40. Tano, K., Mizuno, R., Okada, T., Rakwal, R., Shibato, J., Masuo, Y., Ijiri, K. and Akimitsu, N. (2010) MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 584, 4575-4580.
  41. Tripathi, V., Ellis, J. D., Shen, Z., Song, D. Y., Pan, Q., Watt, A. T., Freier, S. M., Bennett, C. F., Sharma, A., Bubulya, P. A., Blencowe, B. J., Prasanth, S. G. and Prasanth, K. V. (2010) The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 39, 925-938.
  42. Prensner, J. R., Iyer, M. K., Balbin, O. A., Dhanasekaran, S. M., Cao, Q., Brenner, J. C., Laxman, B., Asangani, I. A., Grasso, C. S., Kominsky, H. D., Cao, X., Jing, X., Wang, X., Siddiqui, J., Wei, J. T., Robinson, D., Iyer, H. K., Palanisamy, N., Maher, C. A. and Chinnaiyan, A. M. (2011) Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat. Biotechnol. 29, 742-749.
  43. Schneider, C., King, R. M. and Philipson, L. (1988) Genes specifically expressed at growth arrest of mammalian cells. Cell 54, 787-793.
  44. Mourtada-Maarabouni, M., Pickard, M. R., Hedge, V. L., Farzaneh, F. and Williams, G. T. (2009) GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28, 195-208.
  45. Morrison, L. E., Jewell, S. S., Usha, L., Blondin, B. A., Rao, R. D., Tabesh, B., Kemper, M., Batus, M. and Coon, J. S. (2007) Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3 and 10 on patient response to trastuzumab in metastatic breast cancer. Genes Chromosomes Cancer 46, 397-405.
  46. Smedley, D., Sidhar, S., Birdsall, S., Bennett, D., Herlyn, M., Cooper, C. and Shipley, J. (2000) Characterization of chromosome 1 abnormalities in malignant melanomas. Genes Chromosomes Cancer 28, 121-125.<121::AID-GCC14>3.0.CO;2-O
  47. Luo, J. H., Ren, B., Keryanov, S., Tseng, G. C., Rao, U. N., Monga, S. P., Strom, S., Demetris, A. J., Nalesnik, M., Yu, Y. P., Ranganathan, S. and Michalopoulos, G. K. (2006) Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 44, 1012-1024.
  48. Petrovics, G., Zhang, W., Makarem, M., Street, J. P., Connelly, R., Sun, L., Sesterhenn, I. A., Srikantan, V., Moul, J. W. and Srivastava, S. (2004) Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene 23, 605-611.
  49. Srikantan, V., Zou, Z., Petrovics, G., Xu, L., Augustus, M., Davis, L., Livezey, J. R., Connell, T., Sesterhenn, I. A., Yoshino, K., Buzard, G. S., Mostofi, F. K., McLeod, D. G., Moul, J. W. and Srivastava, S. (2000) PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 97, 12216-12221.
  50. Braconi, C., Valeri, N., Kogure, T., Gasparini, P., Huang, N., Nuovo, G. J., Terracciano, L., Croce, C. M. and Patel, T. (2011) Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 108, 786-791.
  51. Calin, G. A., Liu, C. G., Ferracin, M., Hyslop, T., Spizzo, R., Sevignani, C., Fabbri, M., Cimmino, A., Lee, E. J., Wojcik, S. E., Shimizu, M., Tili, E., Rossi, S., Taccioli, C., Pichiorri, F., Liu, X., Zupo, S., Herlea, V., Gramantieri, L., Lanza, G., Alder, H., Rassenti, L., Volinia, S., Schmittgen, T. D., Kipps, T. J., Negrini, M. and Croce, C. M. (2007) Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 12, 215-229.
  52. Khaitan, D., Dinger, M. E., Mazar, J., Crawford, J., Smith, M. A., Mattick, J. S. and Perera, R. J. (2011) The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 71, 3852-3862.
  53. Yu, M., Ohira, M., Li, Y., Niizuma, H., Oo, M. L., Zhu, Y., Ozaki, T., Isogai, E., Nakamura, Y., Koda, T., Oba, S., Yu, B. and Nakagawara, A. (2009) High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma. Int. J. Oncol. 34, 931-938.
  54. Zhu, Y., Yu, M., Li, Z., Kong, C., Bi, J., Li, J. and Gao, Z. (2011) ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion and survival. Urology 77, 510.e1-5.
  55. Chung, S., Nakagawa, H., Uemura, M., Piao, L., Ashikawa, K., Hosono, N., Takata, R., Akamatsu, S., Kawaguchi, T., Morizono, T., Tsunoda, T., Daigo, Y., Matsuda, K., Kamatani, N., Nakamura, Y. and Kubo, M. (2011) Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci. 102, 245-252.
  56. Matouk, I. J., DeGroot, N., Mezan, S., Ayesh, S., Abu-lail, R., Hochberg, A. and Galun, E. (2007) The H19 non-coding RNA is essential for human tumor growth. PLoS One 2, e845.
  57. Gabory, A., Ripoche, M. A., Yoshimizu, T. and Dandolo, L. (2006) The H19 gene: regulation and function of a non-coding RNA. Cytogenet. Genome Res. 113, 188-193.
  58. Gejman, R., Ansell, P. J., Zhao, J., Weng, C. and Klibanski, A. (2007) Activation of p53 by MEG3 non-coding RNA. J. Biol. Chem. 282, 24731-24742.
  59. Zhang, X., Gejman, R., Mahta, A., Zhong, Y., Rice, K. A., Zhou, Y., Cheunsuchon, P., Louis, D. N. and Klibanski, A. (2010) Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res. 70, 2350-2358.
  60. Wang, J., Liu, X., Wu, H., Ni, P., Gu, Z., Qiao, Y., Chen, N., Sun, F. and Fan, Q. (2010) CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 38, 5366-5383.
  61. Panzitt, K., Tschernatsch, M. M., Guelly, C., Moustafa, T., Stradner, M., Strohmaier, H. M., Buck, C. R., Denk, H., Schroeder, R., Trauner, M. and Zatloukal, K. (2007) Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 132, 330-342.
  62. Tomlins, S. A., Aubin, S. M., Siddiqui, J., Lonigro, R. J., Sefton-Miller, L., Miick, S., Williamsen, S., Hodge, P., Meinke, J., Blase, A., Penabella, Y., Day, J. R., Varambally, R., Han, B., Wood, D., Wang, L., Sanda, M. G., Rubin, M. A., Rhodes, D. R., Hollenbeck, B., Sakamoto, K., Silberstein, J. L., Fradet, Y., Amberson, J. B., Meyers, S., Palanisamy, N., Rittenhouse, H., Wei, J. T., Groskopf, J. and Chinnaiyan, A. M. (2011) Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Sci. Transl. Med. 3, 94ra72.

Cited by

  1. Diagnostic value of long noncoding RNAs for hepatocellular carcinoma vol.96, pp.28, 2017,
  2. Noncoding RNA as regulators of cardiac fibrosis: current insight and the road ahead vol.468, pp.6, 2016,
  3. Long Noncoding RNA Profiles Reveal Three Molecular Subtypes in Glioma vol.20, pp.4, 2014,
  4. SNP@lincTFBS: An Integrated Database of Polymorphisms in Human LincRNA Transcription Factor Binding Sites vol.9, pp.7, 2014,
  5. LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis 2017,
  6. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma vol.36, pp.5, 2015,
  7. Microarray expression profile analysis of long non-coding RNAs in pancreatic ductal adenocarcinoma vol.48, pp.2, 2016,
  8. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma vol.344, pp.1, 2014,
  9. Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer vol.37, pp.2, 2016,
  10. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer vol.468, pp.4, 2015,
  11. Long noncoding RNA HOTAIR involvement in cancer vol.35, pp.10, 2014,
  12. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer vol.36, pp.9, 2015,
  13. A role of long noncoding RNAs in carcinogenesis vol.49, pp.4, 2015,
  14. Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer vol.32, pp.6, 2014,
  15. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma vol.79, 2016,
  16. Characters, functions and clinical perspectives of long non-coding RNAs vol.291, pp.3, 2016,
  17. Analysis of long non-coding RNAs highlights tissue-specific expression patterns and epigenetic profiles in normal and psoriatic skin vol.16, pp.1, 2015,
  18. Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis vol.37, pp.1, 2016,
  19. DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression 2017,
  20. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2 vol.396, 2017,
  21. LncRNAs and neoplasia vol.444, 2015,
  22. NEAT1 negatively regulates miR-218 expression and promotes breast cancer progression vol.20, pp.3, 2017,
  23. Novel long non-coding RNA RP11-119F7.4 as a potential biomarker for the development and progression of gastric cancer 2015,
  24. The novel long noncoding RNA AC138128.1 may be a predictive biomarker in gastric cancer vol.31, pp.11, 2014,
  25. Focusing on long noncoding RNA dysregulation in gastric cancer vol.36, pp.1, 2015,
  26. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis vol.16, pp.2, 2016,
  27. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer vol.36, pp.4, 2015,
  28. Epigenetic Influences in the Aetiology of Cancers Arising from Breast and Prostate: A Hypothesised Transgenerational Evolution in Chromatin Accessibility vol.2013, 2013,
  29. lncRNAtor: a comprehensive resource for functional investigation of long non-coding RNAs vol.30, pp.17, 2014,
  30. lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway vol.79, pp.9-10, 2016,
  31. Upregulation of long noncoding RNA SPRY4-IT1 correlates with tumor progression and poor prognosis in cervical cancer vol.6, pp.9, 2016,
  32. Downregulation of a novel long non-coding RNA, LOC389332, is associated with poor prognosis and tumor progression in clear cell renal cell carcinoma vol.13, pp.3, 2017,
  33. Expression Pattern of Long Non-Coding RNAs in Renal Cell Carcinoma Revealed by Microarray vol.9, pp.6, 2014,
  34. Associations between polymorphisms of HOTAIR and risk of gastric cardia adenocarcinoma in a population of north China vol.36, pp.4, 2015,
  35. Epigenetics and cervical cancer: from pathogenesis to therapy vol.35, pp.6, 2014,
  36. Non-coding RNAs deregulation in oral squamous cell carcinoma: advances and challenges vol.18, pp.5, 2016,
  37. A novel regulatory network among LncRpa, CircRar1, MiR-671 and apoptotic genes promotes lead-induced neuronal cell apoptosis vol.91, pp.4, 2017,
  38. Overexpression of long non‑coding RNA HOTAIR predicts a poor prognosis in patients with acute myeloid leukemia 2015,
  39. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer vol.36, pp.3, 2015,
  40. Prognostic value of lncRNA SOX2OT for Chinese cancer patients: A meta-analysis vol.12, pp.5, 2017,
  41. A critical overview of long non-coding RNA in glioma etiology 2016: an update vol.37, pp.11, 2016,
  42. Potential Biomarkers in Diagnosis of Human Gastric Cancer vol.34, pp.3, 2016,
  43. Expression and Functional Role of Reprogramming-Related Long Noncoding RNA (lincRNA-ROR) in Glioma vol.56, pp.3, 2015,
  44. lncRNA C22orf32-1 contributes to the tumorigenesis of nasopharyngeal carcinoma vol.13, pp.6, 2017,
  45. The LncRNA H19/miR-193a-3p axis modifies the radio-resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1 vol.119, pp.10, 2018,
  46. Long noncoding RNAs: regulation, function and cancer vol.34, pp.2, 2018,
  47. Silencing of Long Noncoding RNA SOX21-AS1 Relieves Neuronal Oxidative Stress Injury in Mice with Alzheimer’s Disease by Upregulating FZD3/5 via the Wnt Signaling Pathway pp.1559-1182, 2018,
  48. The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis vol.13, pp.6, 2018,
  49. CRNDE: An important oncogenic long non-coding RNA in human cancers vol.51, pp.3, 2018,